May 27, 2020
Research in Opioid Utilization, Migraine Therapy and Preterm Birth Recognized with AMCP Foundation Best Poster Awards
Apr 14, 2020
Granata Bio and IBSA Group Announce Strategic Partnership
Jun 18, 2019
Organic Conceptions and Proov Form Strategic Alliance that Brings Hope to Couples Struggling with Infertility
Apr 15, 2019
ASCO, CAP, Open Comment Period for Update to Breast Cancer Testing Guideline
Mar 29, 2019
Pharmascience Inc. launches (Pr)pms-PROGESTERONE 200 mg capsule indicated as an adjunct to postmenopausal estrogen replacement therapy
Mar 25, 2019
Slayback Pharma announces approval of Hydroxyprogesterone Caproate Injection, USP 250 mg/ 1 mL in a single-dose vial, generic equivalent of Makena® Injection 250 mg/ 1 mL
Jan 21, 2019
Slayback Pharma announces launch of Hydroxyprogesterone Caproate Injection, USP 1,250 mg/ 5 mL in a multi-dose vial, the first generic equivalent of Makena® Injection 1,250 mg/ 5 mL multi-dose vial
Jan 21, 2019
IDEXX Introduces Exclusive Point-of-Care Progesterone Test to Its Catalyst Platform
Jan 02, 2019
Slayback Pharma announces FDA approval of Hydroxyprogesterone Caproate Injection, USP 1,250 mg/ 5 mL in a multi-dose vial, the first generic equivalent of Makena® Injection 1,250 mg/ 5 mL multi-dose vial
Nov 13, 2018
Shady Grove Fertility's Landmark Research Study Earns ASRM's Top Scientific Congress Prize Paper Award for Clinical Significance
Oct 17, 2018
New Shady Grove Fertility Study Reveals that Fewer Injections During a Frozen Embryo Transfer (FET) Cycle Resulted in Equivalent Live Birth Rates
Sep 18, 2018
Valeo Pharma and Besins Healthcare Announce Partnership for Utrogestan in Canada
Jan 30, 2018
Ava Unveils New Feature That Detects Bi-Phasic Shift in User's Monthly Cycle to Help Confirm Ovulation
Dec 20, 2017
Amneal Brings Generic for Renvela® to Market and Starts December Strong with Six Product Launches